Structures by: Tilborg A.
Total: 26
L-Prolinium cocrystal of S-Naproxen
C14H14O3,C5H9NO2
CrystEngComm (2013) 15, 17 3341
a=5.6999(2)Å b=6.5428(3)Å c=23.1874(10)Å
α=90.00° β=94.835(4)° γ=90.00°
D-Prolinium cocrystal of S-Naproxen
C14H14O3,C5H9NO2
CrystEngComm (2013) 15, 17 3341
a=5.7713(2)Å b=6.2520(3)Å c=23.8346(11)Å
α=90.00° β=92.047(4)° γ=90.00°
DL-Prolinium cocrystal of RS-Naproxen
C14H14O3,C5H9NO2,H2O
CrystEngComm (2013) 15, 17 3341
a=6.1054(2)Å b=12.4750(5)Å c=49.1664(13)Å
α=90.00° β=90.00° γ=90.00°
L-Prolinium cocrystal of RS-Naproxen
C14H14O3,C5H9NO2,H2O
CrystEngComm (2013) 15, 17 3341
a=13.122(2)Å b=5.8980(10)Å c=24.075(3)Å
α=90.00° β=95.560(5)° γ=90.00°
(E)-2-methoxy-6-{[(3-nitrophenyl)imino]methyl}phenol
C14H12N2O4
CrystEngComm (2015) 17, 18 3509
a=4.7895(3)Å b=11.3446(10)Å c=12.0610(9)Å
α=93.472(7)° β=100.357(6)° γ=94.022(6)°
(E)-2-methoxy-6-{[(3-nitrophenyl)imino]methyl}phenol
C14H12N2O4
CrystEngComm (2015) 17, 18 3509
a=12.8418(3)Å b=7.5487(2)Å c=26.4610(6)Å
α=90.00° β=90.00° γ=90.00°
P3-PolymorphI-Pbca
C14H12N2O4
CrystEngComm (2015) 17, 18 3509
a=12.4915(15)Å b=7.5972(14)Å c=26.1737(18)Å
α=90.00° β=90.00° γ=90.00°
C6H10N2O2
C6H10N2O2
Acta Crystallographica Section B (2011) 67, 6 499-507
a=6.5030(10)Å b=6.4180(10)Å c=16.416(3)Å
α=90.00° β=92.087(4)° γ=90.00°
Benserazide substitute
C20H16N2O
Acta Crystallographica Section E (2015) 71, 2 180-183
a=7.8858(5)Å b=7.9226(8)Å c=13.0182(13)Å
α=104.267(9)° β=103.576(7)° γ=91.967(7)°
C11H11N2O,Cl,H2O
C11H11N2O,Cl,H2O
Acta crystallographica Section B, Structural science, crystal engineering and materials (2015) 71, Pt 4 447-454
a=5.1830(6)Å b=16.808(7)Å c=27.247(3)Å
α=90.00° β=90.00° γ=90.00°
C11H9BrN2O
C11H9BrN2O
Acta crystallographica Section B, Structural science, crystal engineering and materials (2015) 71, Pt 4 447-454
a=10.1389(7)Å b=7.5691(5)Å c=27.0498(15)Å
α=90.00° β=90.00° γ=90.00°
C11H9N3O3,3(H2O)
C11H9N3O3,3(H2O)
Acta crystallographica Section B, Structural science, crystal engineering and materials (2015) 71, Pt 4 447-454
a=7.0408(3)Å b=8.4596(5)Å c=11.4455(7)Å
α=89.438(5)° β=86.904(4)° γ=82.072(4)°
C11H10BrN2O,Cl,H2O
C11H10BrN2O,Cl,H2O
Acta crystallographica Section B, Structural science, crystal engineering and materials (2015) 71, Pt 4 447-454
a=6.845(5)Å b=7.141(5)Å c=13.905(5)Å
α=101.723(5)° β=95.164(5)° γ=100.511(5)°
C11H12N3O3,Cl
C11H12N3O3,Cl
Acta crystallographica Section B, Structural science, crystal engineering and materials (2015) 71, Pt 4 447-454
a=21.9100(7)Å b=8.0131(3)Å c=14.3802(4)Å
α=90.00° β=97.325(3)° γ=90.00°
Complex of trimethoprim and fumaric acid
C14H19N4O3,C4H3O4
Acta crystallographica Section B, Structural science, crystal engineering and materials (2015) 71, Pt 4 406-415
a=10.4700(5)Å b=14.6637(10)Å c=15.0285(10)Å
α=61.535(7)° β=83.550(5)° γ=71.020(5)°
Dicyclohexylaminium (<i>S</i>)-2-(1,3-dioxoisoindolin-2-yl)-3-(1<i>H</i>-indol-3-yl)propanoate dimethylformamide solvate monohydrate
C12H24N,C19H13N2O4,C3H7NO,H2O
Acta Crystallographica Section E (2010) 66, 12 o3175-o3176
a=9.08840(10)Å b=15.0206(3)Å c=24.4749(5)Å
α=90.00° β=90.00° γ=90.00°
IB07
C19H13N3O6
Acta Crystallographica Section E (2011) 67, 8 o2116
a=7.0569(3)Å b=15.5302(8)Å c=7.6947(4)Å
α=90.00° β=95.415(4)° γ=90.00°
Stanozolol / malonic acid cocrystal
C21H32N2O,C3H4O4
Crystal Growth & Design (2014) 14, 7 3408
a=10.6644(7)Å b=7.2335(5)Å c=15.0947(10)Å
α=90.00° β=106.016(7)° γ=90.00°
Stanozolol / D-phenyllactic acid cocrystal
2(C21H32N2O),C9H10O3,C2H3N
Crystal Growth & Design (2014) 14, 7 3408
a=58.6098(12)Å b=7.5624(2)Å c=10.7139(4)Å
α=90.00° β=97.989(2)° γ=90.00°
Stanozolol / 6-hydroxy-2-naphthoic acid
C21H32N2O,C11H8O3
Crystal Growth & Design (2014) 14, 7 3408
a=7.9530(6)Å b=8.6403(7)Å c=10.4582(7)Å
α=83.337(6)° β=86.973(6)° γ=75.431(7)°
C9H7NS2
C9H7NS2
Crystal Growth & Design (2015) 15, 5 2461
a=34.675(3)Å b=34.675(3)Å c=4.0950(4)Å
α=90.00° β=90.00° γ=120.00°
C33 Polymorph I
C9H7NS2
Crystal Growth & Design (2015) 15, 5 2461
a=6.2423(2)Å b=11.5747(3)Å c=12.7785(4)Å
α=90.00° β=101.780(3)° γ=90.00°
D-prolinium cocrystal of fumaric acid
2(C5H9NO2),C4H4O4
Crystal Growth & Design (2013) 13, 6 2373
a=9.5830(10)Å b=9.0370(10)Å c=10.1790(10)Å
α=90.00° β=110.837(9)° γ=90.00°
L-prolinium cocrystal of fumaric acid
2(C5H9NO2),C4H4O4
Crystal Growth & Design (2013) 13, 6 2373
a=9.5896(4)Å b=9.0386(3)Å c=10.1964(5)Å
α=90.00° β=110.845(5)° γ=90.00°
D-prolinamidium fumarate salt
2(C5H11N2O),C4H2O4,H2O
Crystal Growth & Design (2013) 13, 6 2373
a=9.8307(5)Å b=7.1796(3)Å c=12.8464(6)Å
α=90.00° β=99.217(5)° γ=90.00°
DL-prolinium cocrystal of fumaric acid
2(C5H9NO2),C4H4O4
Crystal Growth & Design (2013) 13, 6 2373
a=17.2025(6)Å b=9.7993(3)Å c=27.6106(19)Å
α=90.00° β=90.00° γ=90.00°